Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04996849 · ClinicalTrials.gov registry record
Contemporary Characteristics of Penile Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 499
- Enrollment target
NCT04996849: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT04996849 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 499 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04996849 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 499 participants
- Enrollment target
Study Summary
This study develops a prospective database of patients who are evaluated and treated for penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors, treatment, complications, and tumor progression. It will also prospectively validate the importance of pathological prognostic factors previously reported and outcome related to contemporary treatment.
Primary Outcome
Descriptive statistics will be utilized where applicable to address questions relevant to the study aims.
Interventions
- OTHER Questionnaire Administration
- OTHER Data Capture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2004-04-22 |
| Est. Completion | 2025-09-17 |
Why NCT04996849 stopped before completion
NCT04996849 is an observational study that tracks outcomes without assigning an intervention. The registered 499 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04996849 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04996849 about?
NCT04996849 is a clinical study titled "Contemporary Characteristics of Penile Cancer". This study develops a prospective database of patients who are evaluated and treated for penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors, treatment, complications, and tumor progression. It will also prospectively validate the importance of pathological prognos...
What is the current status of trial NCT04996849?
This trial is currently terminated. The enrollment target is 499 participants. The study started on 2004-04-22. Estimated completion is 2025-09-17.
What interventions are being tested in trial NCT04996849?
The interventions under investigation include: Questionnaire Administration (OTHER), Data Capture (OTHER).
Who is sponsoring clinical trial NCT04996849?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI